Live News EQUITY FLASH L impact Nov 03, 2026, 02:30 PM UTC UBS Raises Iovance Biotherapeutics Price Target to $8 From $7 Valid market news retained in the public archive without immediate LiveCast distribution. IOVA SquawkNews Desk